Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
IO-202
i
Other names:
IO-202, IO202, IO 202
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Immune-Onc Therap
Drug class:
ILT-3 inhibitor
Related drugs:
‹
IO-312 (0)
MK-0482 (0)
NGM936 (0)
YTS104 (0)
IO-312 (0)
MK-0482 (0)
NGM936 (0)
YTS104 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
IO-202
Sensitive: B - Late Trials
IO-202
Sensitive
:
B
IO-202
Sensitive: B - Late Trials
IO-202
Sensitive
:
B
LILRB4 overexpression
Acute Myelogenous Leukemia
LILRB4 overexpression
Acute Myelogenous Leukemia
IO-202
Sensitive: C4 – Case Studies
IO-202
Sensitive
:
C4
IO-202
Sensitive: C4 – Case Studies
IO-202
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login